Announced details
Cancer immunotherapy for glioblastoma and brain tumors
The parties have entered into a joint research agreement concerning cancer immunotherapy for brain tumors using CAR-eNK® cells. The current development is part of the joint research project.
Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University. Assistant Professor Hatae Ryusuke (波多江龍亮) is listed as a presenter. Other details, including the location, representative, capital and year established, are Not disclosed.
株式会社ヘリオス Kobe Research Center (full address Not disclosed)
Information on the impact on business performance is Not disclosed.
The company does not address Contract Value / Offering price.
44th Annual Meeting of the Japan Society for Neuro-Oncology
| Item | Details |
|---|---|
| Names of Products / Services Covered | Dual CAR-eNK® cells, CAR-eNK® cells, eNK® cells (AKT-01/HLCN061) |
| Counterparty | Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, National University Corporation |
| Counterparty overview | Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University. Assistant Professor Hatae Ryusuke (波多江龍亮) is listed as a presenter. Other details, including the location, representative, capital and year established, are Not disclosed. |
| Relationship with the Company | The parties have entered into a joint research agreement concerning cancer immunotherapy for brain tumors using CAR-eNK® cells. The current development is part of the joint research project. |
| Contract Date | Announcement made on 14 October 2025 (the contract execution date itself is Not disclosed) |
| Launch date | A conference poster presentation is scheduled for 30 November 2026, from 22:00 to 22:30. The date on which treatment will become available is Not disclosed. |
| Applicable area | Cancer immunotherapy for glioblastoma and brain tumors |
| Location | 株式会社ヘリオス Kobe Research Center (full address Not disclosed) |
| Impact on Business Performance | Information on the impact on business performance is Not disclosed. |
| Source | 44th Annual Meeting of the Japan Society for Neuro-Oncology |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because it is being conducted as part of a joint research project with the Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University.